Clinical Trials Monitor/
Not_yet_recruitingNCT07396792

Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram Analyzed With Machine Learning Models

Sponsor: I.M. Sechenov First Moscow State Medical University

Trial Details

ConditionArterial Hypertension, Heart Rhythm Disorders, Valvular Heart Diseases, Heart Failure, Diabetes Mellitus, Chronic Kidney Disease (Stage 3-4), Metabolic Syndrome, Coronary Artery Disease
StatusNot_yet_recruiting
Participants4,000
Est. Completion1 Mar 2028
Last Updated16 Apr 2026

Primary Outcome

Parameters of single-channel ECG that significantly correlate with the presence of various cardiac and cardiac-associated pathologies; Determination of sensitivity of various cardiac and cardiac-associated pathologies of multivariate models for analyzing single-channel electrocardiogram data; Determination of specificity of various cardiac and cardiac-associated pathologies of multivariate models for analyzing single-channel electrocardiogram data; Determination of diagnostic accuracy of various cardiac and cardiac-associated pathologies of multivariate models for analyzing single-channel electrocardiogram data

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. The presence of written informed consent of the patient to participate in the study 2. Availability of examination data allowing for the verification or exclusion of cardiac and cardiac-associated pathology 3. Age 18 years old and older Non-inclusion criteria: 1. Patients with an implanted permanent pacemaker; 2. ECG changes that prevent spectral analysis; 3. Conditions that may impair the quality of the ECG recording (Parkinson's disease, essential tremor, etc.); 4. Conditions that make ECG recording in lead I impossible (congenital anomalies of the upper limbs, traumatic amputation of the upper limbs). 5. Lack of written informed consent from the patient to participate in the study. Exclusion Criteria: 1. Poor quality of the ECG recording on a single-channel ECG monitor 2. Insufficient examination data to verify or exclude cardiac or cardiac-associated pathology; 3. Patient's unwillingness to continue participating in the study for any reason.

View Registry Entry

Related Analysis

Landmark 5,000-Patient Study Tests Single-Channel ECG Screening for Multiple Cardiac Conditions — Potential Game-Changer for Primary Care

A groundbreaking 5,000-patient study is developing machine learning models to screen for eight major cardiac and metabolic conditions using simple single-channel ECG recordings. This could revolutionise cardiovascular screening in primary care and resource-limited settings.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service